proglumide has been researched along with Akinetic-Rigid Variant of Huntington Disease in 1 studies
Proglumide: A drug that exerts an inhibitory effect on gastric secretion and reduces gastrointestinal motility. It is used clinically in the drug therapy of gastrointestinal ulcers.
proglumide : A racemate composed of equal amounts of (R)- and (S)-proglumide. A non-selective CCK antagonist that was used primarily for treatment of stomach ulcers, but has been replaced by newer drugs.
N(2)-benzoyl-N,N-dipropyl-alpha-glutamine : A dicarboxylic acid monoamide obtained by formal condensation of the alpha-carboxy group of N-benzoylglutamic acid with dippropylamine.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Piolti, R | 1 |
| Appollonio, I | 1 |
| Perego, M | 1 |
| Pozzi, C | 1 |
| Rovati, L | 1 |
| Ferrarese, C | 1 |
| Frattola, L | 1 |
1 trial available for proglumide and Akinetic-Rigid Variant of Huntington Disease
| Article | Year |
|---|---|
Proglumide, a cholecystokinin receptor antagonist, reduces neuroleptic action in Huntington's chorea.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Drug Therapy, Combination; Female; Haloperidol; Human | 1995 |